While the extant evidence is not yet strong enough to support the routine use of medications used for the treatment of CVRFs to target psychiatric symptomatology in bipolar disorder, there are some interesting findings related to statins and ACE inhibitors that invite rigorous clinical trials. Here, ACE is linked to bipolar disorder.